{
  "abstract": "The NHS spent £574m on tirzepatide (Mounjaro) last year, an almost fivefold annual increase and around 5% of its total prescribing bill of £11.6bn, new data show.",
  "authors": [
    {
      "affiliations": [
        "Sheffield"
      ],
      "name": "Emma Wilkinson"
    }
  ],
  "title": "Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it",
  "uid": "329691d5-5aa9-5ea2-80b7-8c60463efd7f"
}